Controlled nucleation of topological defects in the stripe domain patterns of Lateral multilayers with Perpendicular Magnetic Anisotropy: competition between magnetostatic, exchange and misfit interactions

Magnetic lateral multilayers have been fabricated on weak perpendicular magnetic anisotropy amorphous Nd-Co films in order to perform a systematic study on the conditions for controlled nucleation of topological defects within their magnetic stripe domain pattern. A lateral thickness modulation of period $w$ is defined on the nanostructured samples that, in turn, induces a lateral modulation of both magnetic stripe domain periods $\lambda$ and average in-plane magnetization component $M_{inplane}$. Depending on lateral multilayer period and in-plane applied field, thin and thick regions switch independently during in-plane magnetization reversal and domain walls are created within the in-plane magnetization configuration coupled to variable angle grain boundaries and disclinations within the magnetic stripe domain patterns. This process is mainly driven by the competition between rotatable anisotropy (that couples the magnetic stripe pattern to in-plane magnetization) and in-plane shape anisotropy induced by the periodic thickness modulation. However, as the structural period $w$ becomes comparable to magnetic stripe period $\lambda$, the nucleation of topological defects at the interfaces between thin and thick regions is hindered by a size effect and stripe domains in the different thickness regions become strongly coupled.Comment: 10 pages, 7 figures, submitted to Physical Review

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide

Monogenic autoinflammatory diseases are rare conditions caused by genetic abnormalities affecting the innate immunity. Previous therapeutic strategies had been mainly based on results from retrospective studies and physicians' experience. However, during the last years, the significant improvement in their genetic and pathogenic knowledge has been accompanied by a remarkable progress in their management. The relatively recent identification of the inflammasome as the crucial pathogenic mechanism causing an aberrant production of interleukin 1β (IL-1β) in the most frequent monogenic autoinflammatory diseases led to the introduction of anti–IL-1 agents and other biologic drugs as part of the previously limited therapeutic armamentarium available. Advances in the treatment of autoinflammatory diseases have been favored by the use of new biologic agents and the performance of a notable number of randomized clinical trials exploring the efficacy and safety of these agents. Clinical trials have contributed to increase the level of evidence and provided more robust therapeutic recommendations. This review analyzes the treatment of the most frequent monogenic autoinflammatory diseases, namely, familial Mediterranean fever, tumor necrosis factor receptor–associated periodic fever syndrome, hyperimmunoglobulin D syndrome/mevalonate kinase deficiency, and cryopyrin-associated periodic syndromes, together with periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis syndrome, which is the most common polygenic autoinflammatory disease in children, also occurring in adult patients. Finally, based on the available expert consensus recommendations and the highest level of evidence of the published studies, a practical evidence-based guideline for the treatment of these autoinflammatory diseases is proposed

Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK – Results from micro-simulation model

Background: Low-dose aspirin therapy reduces the risk of cardiovascular disease and may have a positive effect on the prevention of colorectal cancer. We evaluated the population-level expected effect of regular low-dose aspirin use on cardiovascular disease (CVD), colorectal cancer (CRC), gastrointestinal bleeding, symptomatic peptic ulcers, and intracranial hemorrhage, using a microsimulation study design. Methods: We used individual-level state transition modeling to assess the impact of aspirin in populations aged 50–59 or 60–69 years old indicated for low-dose aspirin usage for primary or secondary CVD prevention. Model parameters were based on data from governmental agencies from the UK or recent publications. Results: In the 50–59 years cohort, a decrease in incidence rates (IRs per 100 000 person years) of non-fatal CVD (-203 and -794) and fatal CVD (-97 and-381) was reported in the primary and secondary CVD prevention setting, respectively. The IR reduction of CRC (-96 and -93) was similar for primary and secondary CVD prevention. The IR increase of non-fatal (116 and 119) and fatal safety events (6 and 6) was similar for primary and secondary CVD prevention. Similar results were obtained for the 60–69 years cohort. Conclusions: The decrease in fatal CVD and CRC events was larger than the increase in fatal safety events and this difference was more pronounced when low-dose aspirin was used for secondary compared to primary CVD prevention. These results provide a comprehensive image of the expected effect of regular low-dose aspirin therapy in a UK population indicated to use aspirin for CVD prevention. © 202

Improvement of lifetime in the power electronic drive of a BLDCM through the optimization of Fuzzy Logic Control

[EN] Power electronics elements lifetime in BLDCM drives can be affected due to power losses by conduction and switching during their operation. These losses normally aren´t consider in the design of controller, hence the controller lifetime is reduced or generate early failures. In this work, a fuzzy controller optimization through of PSO algorithm is proposed, this controller design considers the semiconductors temperature and the speed of BLDCM, it allows to increase power electronics lifetime at the same time that the speed desired is achieved. Finally, The Fuzzy-PSO controller results are compared with a PID conventional controller and Fuzzy conventional controller. These results are superior in comparison to conventional controllers since increase the power electronics lifetime and reach the speed set point. Additionally, the co-simulation as a methodology that allows to design, to implement and to validate prototypes in a reliable way. In this co-simulation the power electronics devices, the BLDCM and the controller proposed were designed in MultisimTM and LabVIEWTM from National Instrument (NI).[ES] El tiempo de vida útil en los elementos de electrónica de potencia en accionamientos eléctricos para motores de corriente directa sin escobillas BLDCM (por sus siglas en inglés Brushless Direct Current Motor), pueden verse afectados debido a las pérdidas por conmutación y conducción que aparecen durante su operación. Estas pérdidas normalmente no se considerarán en el diseño del controlador, por lo que su vida útil disminuye drásticamente o genera fallas prematuramente. El presente trabajo propone la optimización de un controlador difuso mediante el algoritmo PSO (por sus siglas en inglés Particle Swarm Optimization), este diseño considera la temperatura en los semiconductores y la velocidad mecánica del BLDCM, lo que permite incrementar la vida útil de los semiconductores utilizados en los módulos de electrónica de potencia, al mismo tiempo que alcanza la velocidad de referencia asignada. Finalmente, los resultados del controlador difuso optimizado (Difuso-PSO) propuesto se comparan con un controlador proporcional, derivativo e integral (PID) convencional, y un controlador difuso convencional. Estos resultados muestran ser superiores en comparación a los controladores convencionales, ya que incrementan el tiempo de vida de los semiconductores y alcanzan las velocidades de referencia establecidas. Adicionalmente, se emplea la co-simulación como una herramienta que permite diseñar, implementar y validar los resultados de manera confiable. En esta co-simulación la electrónica de potencia, el BLDCM y el controlador propuesto fueron diseñados en MultisimTM y LabVIEWTM de National Instrument (NI).Esta investigación es un producto del proyecto 266632 “Laboratorio Binacional para la Gestión Inteligente de la Sustentabilidad Energética y la Formación Tecnológica” financiado a través de Fondo CONACYT SENER de Sustentabilidad Energética (S0019201401).Garcia Lopez, M.; Ponce, P.; Soriano, LA.; Molina, A.; Rodriguez, JJ. (2018). Mejora de la Vida Útil en los Módulos de Electrónica de Potencia de un BLDCM Mediante la Optimización de un Control Difuso. Revista Iberoamericana de Automática e Informática. 16(1):66-78. https://doi.org/10.4995/riai.2018.9078SWORD667816

Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study

n/

Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer

Background:We conducted a phase 1 trial in patients with locally advanced cervical cancer by injecting 0.5 ml of the CK2-antagonist CIGB-300 in two different sites on tumours to assess tumour uptake, safety, pharmacodynamic activity and identify the recommended dose.Methods:Fourteen patients were treated with intralesional injections containing 35 or 70 mg of CIGB-300 in three alternate cycles of three consecutive days each before standard chemoradiotherapy. Tumour uptake was determined using 99 Tc-radiolabelled peptide. In situ B23/nucleophosmin was determined by immunohistochemistry.Results:Maximum tumour uptake for CIGB-300 70-mg dose was significantly higher than the one observed for 35 mg: 16.1±8.9 vs 31.3±12.9 mg (P=0.01). Both, AUC 24h and biological half-life were also significantly higher using 70 mg of CIGB-300 (P<0.001). Unincorporated CIGB-300 diffused rapidly to blood and was mainly distributed towards kidneys, and marginally in liver, lungs, heart and spleen. There was no DLT and moderate allergic-like reactions were the most common systemic side effect with strong correlation between unincorporated CIGB-300 and histamine levels in blood. CIGB-300, 70 mg, downregulated B23/nucleophosmin (P=0.03) in tumour specimens.Conclusion:Intralesional injections of 70 mg CIGB-300 in two sites (0.5 ml per injection) and this treatment plan are recommended to be evaluated in phase 2 studies.Fil: Sarduy, M. R.. Medical-surgical Research Center; CubaFil: García, I.. Centro de Ingeniería Genética y Biotecnología; CubaFil: Coca, M. A.. Clinical Investigation Center; CubaFil: Perera, A.. Clinical Investigation Center; CubaFil: Torres, L. A.. Clinical Investigation Center; CubaFil: Valenzuela, C. M.. Centro de Ingeniería Genética y Biotecnología; CubaFil: Baladrón, I.. Centro de Ingeniería Genética y Biotecnología; CubaFil: Solares, M.. Hospital Materno Ramón González Coro; CubaFil: Reyes, V.. Center For Genetic Engineering And Biotechnology Havana; CubaFil: Hernández, I.. Isotope Center; CubaFil: Perera, Y.. Centro de Ingeniería Genética y Biotecnología; CubaFil: Martínez, Y. M.. Medical-surgical Research Center; CubaFil: Molina, L.. Medical-surgical Research Center; CubaFil: González, Y. M.. Medical-surgical Research Center; CubaFil: Ancízar, J. A.. Centro de Ingeniería Genética y Biotecnología; CubaFil: Prats, A.. Clinical Investigation Center; CubaFil: González, L.. Centro de Ingeniería Genética y Biotecnología; CubaFil: Casacó, C. A.. Clinical Investigation Center; CubaFil: Acevedo, B. E.. Centro de Ingeniería Genética y Biotecnología; CubaFil: López Saura, P. A.. Centro de Ingeniería Genética y Biotecnología; CubaFil: Alonso, Daniel Fernando. Universidad Nacional de Quilmes; ArgentinaFil: Gómez, R.. Elea Laboratories; ArgentinaFil: Perea Rodríguez, S. E.. Center For Genetic Engineering And Biotechnology Havana; Cuba. Centro de Ingeniería Genética y Biotecnología; Cub

Binational reflections on pathways to groundwater security in the Mexico-United States borderlands

Shared groundwater resources between Mexico and the United States are facing unprecedented stressors. We reflect on how to improve water security for groundwater systems in the border region. Our reflection begins with the state of groundwater knowledge, and the challenges groundwater resources face from a physical, societal and institutional perspective. We conclude that the extent of ongoing cooperation frameworks, joint and remaining research efforts, from which alternative strategies can emerge, still need to be developed. The way forward offers a variety of cooperation models as the future offers rather complex, shared and multidisciplinary water challenges to the Mexico–US borderlands

Binational reflections on pathways to groundwater security in the Mexico–United States borderlands

Shared groundwater resources between Mexico and the United States are facing unprecedented stressors. We reflect on how to improve water security for groundwater systems in the border region. Our reflection begins with the state of groundwater knowledge, and the challenges groundwater resources face from a physical, societal and institutional perspective. We conclude that the extent of ongoing cooperation frameworks, joint and remaining research efforts, from which alternative strategies can emerge, still need to be developed. The way forward offers a variety of cooperation models as the future offers rather complex, shared and multidisciplinary water challenges to the Mexico–US borderlands

The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus

Objectives: Patients with prosthetic joint infections (PJIs) not suitable for curative surgery may benefit from suppressive antibiotic therapy (SAT). However, the usefulness of SAT in cases with a draining sinus has never been investigated. Methods: A multicentre, retrospective observational cohort study was performed in which patients with a PJI and a sinus tract were eligible for inclusion if managed conservatively and if sufficient follow-up data were available (i.e. at least 2 years). SAT was defined as a period of &gt; 6 months of oral antibiotic therapy. Results: SAT was initiated in 63 of 72 (87.5 %) included patients. Implant retention during follow-up was the same in patients receiving SAT vs. no SAT (79.4 % vs. 88.9 %; pCombining double low line0.68). In total, 27 % of patients using SAT experienced side effects. In addition, the occurrence of prosthetic loosening in initially fixed implants, the need for surgical debridement, or the occurrence of bacteremia during follow-up could not be fully prevented with the use of SAT, which still occurred in 42 %, 6.3 %, and 3.2 % of cases, respectively. However, the sinus tract tended to close more often (42 % vs. 13 %; pCombining double low line0.14), and a higher resolution of pain was observed (35 % vs. 14 %; pCombining double low line0.22) in patients receiving SAT. Conclusions: SAT is not able to fully prevent complications in patients with a draining sinus. However, it may be beneficial in a subset of patients, particularly in those with pain or the hindrance of a draining sinus. A future prospective study, including a higher number of patients not receiving SAT, is needed